BeyondSpring Inc. (NASDAQ: BYSI) Stock Information | RedChip

BeyondSpring Inc. (NASDAQ: BYSI) Listen to this Section


$1.74
-0.0800 ( -4.40% ) 15.0K

BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It has two reportable segments Plinabulin pipeline and the TPD platform.

Market Data


Open


$1.74

Previous close


$1.82

Volume


15.0K

Market cap


$70.12M

Day range


$1.73 - $1.86

52 week range


$0.65 - $4.00

Insider Ownership Transactions

Total Amount Purchased: 0.00 | $ 0.00

Date Type Amount Purchased Purchaser
No records found.

SEC Fillings


Form Type Description Pages Date
6-k Quarterly Reports 2 Aug 06, 2024
6-k Quarterly Reports 5 Jun 12, 2024
20-f Annual reports 26 Apr 29, 2024
6-k Quarterly Reports 1 Mar 18, 2024
6-k Quarterly Reports 2 Feb 26, 2024
6-k Quarterly Reports 19 Feb 02, 2024
6-k Quarterly Reports 1 Jan 16, 2024
6-k Quarterly Reports 2 Jan 10, 2024
6-k Quarterly Reports 2 Dec 18, 2023
6-k Quarterly Reports 2 Oct 30, 2023

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.